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Purpose: Ureteropelvic junction (UPJ) obstruction is by far the most 
common cause of pediatric hydronephrosis. The widespread use of 
antenatal ultrasonography and modern imaging techniques has resulted 
in earlier and more common diagnosis of hydronephrosis. However, com-
pared with this increased earlier detection, little has changed regarding 
the management of hydronephrosis. Through this review, we wish to 
provide an overview of the studies done to date and search for areas that 
warrant further study.
Materials and Methods: Through PubMed, we reviewed the literature on 
the subject of UPJ obstruction in the pediatric population. We also present 
data from our institution regarding recent trends in the evaluation and 
treatment of UPJ obstructions.
Results: In addition to conventional imaging studies, attempts are being 
made at making use of biochemical parameters (e.g., β2 m, N-acetyl-β- 
D-glucosaminidase [NAG], transforming growth factor [TGF]-β, etc.) as 
not only indicators of intervention but also prognostic factors during 
follow-up. Although we routinely use radionuclide imaging to evaluate 
renal function, a more accurate novel tool that can represent true renal 
function is needed. With the development in the field of laparoscopic and 
minimally invasive surgery, the role of laparoscopy and robot-assisted 
laparoscopic pyeloplasty is expanding, even in the pediatric population. 
However, relatively little is known about the factors that might be 
associated with postoperative outcomes.
Conclusions: Not missing the optimal time for surgical intervention is as 
important as avoiding unnecessary surgery. Continuous development and 
refining of surgical skills for UPJ obstruction repair are requisites for 
(pediatric) urologists as is in-depth basic research of the disease. (Korean 
J Urol 2009;50:423-431)
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INTRODUCTION
　Ureteropelvic junction (UPJ) obstruction is by far the most 
common cause of pediatric hydronephrosis, occurring in 1 per 
1,000-2,000 newborns. Widespread use of antenatal ultrasono-
graphy and the advent of modern imaging techniques have 
resulted in earlier and more common diagnosis of hydro-
nephrosis.1,2
　Obstruction is more commonly found in boys than in girls, 
especially in the newborn period, when the ratio exceeds 2:1. 
Left-sided lesions predominate, particularly in the neonate, up 
to approximately 67%, and bilateral cases are observed in 
10-40% of cases; however, fewer than 5% of patients require 
bilateral repair.3
　With more early-detected cases, the management of pediatric 
UPJ obstruction remains more important. Choosing an optimal 
therapeutic regimen is difficult due to the high variability in 
function, degree of obstruction, extent of damage, and potential 
for regeneration in growing kidneys.
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ETIOLOGY
1. Intrinsic abnormalities
　In the embryogenesis, the UPJ is formed during the fifth 
week. By weeks 10-12 of gestation, the initial tubular lumen 
of the ureteric bud becomes recanalized, and the UPJ area is 
the last to recanalize. Inadequate canalization of this area is the 
main embryological explanation of UPJ obstruction.4 Several 
growth factors may control embryogenesis of UPJ. Researchers 
propose that improper innervation with diminished synaptic 
vesicles may be a factor in the development of UPJ obstruction, 
and factors involved in neuronal development, such as protein 
gene product (PGP) 9.5 (a general neuronal marker), S-100 
protein (a nerve supporting cell marker), synaptophysin (a 
synapse vesical marker), and nerve growth factor receptor were 
all decreased in the resected specimens of UPJ.
　The induction of kidney mesenchyme by the ureteric bud is 
mediated by a transcription factor Pax-2.5 Other factors, such 
as c-ret, kdn-1, and wt1, also may be involved. A well-known 
growth factor, transforming growth factor (TGF), may account 
for the abnormal smooth musculature in the obstructed renal 
pelvis.6 More research certainly is needed to clarify the 
molecular basis of the UPJ obstruction. This intrinsic obstruc-
tion is evident as the ureteral narrowing with angulation is 
found. During exploration, a catheter usually is passed to the 
renal pelvis without resistance, and this is evidence of the fact 
that the true narrowing is not a main pathologic change in UPJ 
obstruction. Some claimed the presence of remnant valvular 
mucosal folds, while others postulate the disproportionate abun-
dance of longitudinal muscles as the cause of this condition.7
　The most attractive theory is that the obstruction is secondary 
to muscular discontinuity, which disrupts the coordinated 
motion of smooth muscle cells and may result in impeded 
transport of urine and blockage of the downward transmission 
of ureteral peristalsis.8 This absence or disorientation of smooth 
muscle fibers at UPJ is clearly evident on electron microscope 
evaluation with the findings of hypotrophy/hypertrophy of the 
smooth muscle and its replacement with excessive collagen, 
combined with diminution of nerve terminals and nerves at the 
stenotic portion.9
　One study had identified altered expression of interstitial 
Cajal cells in obstructed UPJ specimens, which are normally 
intercalated between nerve terminal and smooth muscle cells, 
providing a means of transducing signals from neurotrans-
mitters and mediating neurotransmission.10 This suggests that 
UPJO may cause the failure of transmission of peristaltic waves 
across the UPJ, resulting in the failure of urine to be propelled 
from the renal pelvis into the ureter.
2. Extrinsic abnormalities
　Extrinsic obstructions secondary to bands, kinks, and aber-
rant vessels also are commonly encountered. In 40% of cases, 
an aberrant, accessory, or early-branching lower pole segment 
vessel is found and observed to compress the ureter, causing 
mechanical obstruction. In this case, with the increased urine 
volume, the UPJ angulation with intrapelvic volume expansion 
causes increased resistance and obstruction.11 Further angulation 
may occur as it becomes adherent to an inflammatory process. 
The presence of such a vessel in the vicinity of UPJ has gained 
recent attention after the advent of the endourological manage-
ment. The anterior surface of the renal pelvis is associated with 
a lower pole vessel in 65% of cases, whereas the posterior 
surface is in contact with a vessel in 6% of the kidneys 
examined.12 This information is relevant for the endoscopic 
incision of UPJ, making lateral incision the only safe option.
　Patients with extrinsic obstructions present rather late in 
childhood, with intermittent abdominal or flank pain.13 Hor-
seshoe or pelvic kidney, duplex collecting systems, and other 
rotational abnormalities also may cause UPJ obstruction.14 
Cases of so-called high inserted ureter-to-renal pelvis exist, but 
this is presumed to be a secondary phenomenon to obstruction 
because the ureteral insertion seems to be higher in cases of 
dilated renal pelvis.
PATHOPHYSIOLOGY
　The urinary drainage from renal pelvis to ureter is deter-
mined by many factors. Urine volume and flow, the degree of 
UPJ obstruction, the functional capacity of glomerulus and 
collecting system, and the compliance of renal pelvis are the 
4 main variables determining the pelvic pressure. At first, in 
response to the increased pelvic pressure, the renal pelvis 
dilates and ureteral muscles show hypertrophy.15 In the 
intrarenal type of obstruction, the degree of dilation is restricted 
by renal parenchyme; thus, the damage usually is more severe 
than the extrarenal type. Parenchymal damage by UPJ obstruc-
tion is well documented by histologic changes, which are more 
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severe in cases of differential function of less than 35%.16
　Experimental studies using artificially made complete ob-
structions showed changes that suggest the upward transmission 
of ureteral pressure in an obstructed kidney and the subsequent 
effects on tubular pressure, tubular function, renal blood flow 
(RBF), and glomerular filtration rate (GFR).17-20 The urinary 
obstruction results in the impairment of all renal functions 
except urinary dilution; however, the elevation of ureteral 
pressure above a certain point had no further effect on intra-
tubular pressure. With complete ureteral ligation, a rise in renal 
pelvic pressure occurs, which is only transitory; over a period 
of hours, the renal pelvic pressure falls in concert with RBF. 
Also, the intrapelvic pressure in patients with UPJ obstruction 
most often is in the normal range assessed at the time of 
surgery. Researchers propose that the expansion of the renal 
pelvis is protective by dampening out of the pressure.
　Koff proposed the concept of pressure- or volume-dependent 
flow.21,22 In instances of intrinsic obstruction, at low urinary 
flow rates, no obstruction exists; however, as the flow rate 
increases, the urinary bolus are not conducted, causing the renal 
pelvis to distend. This concept is called a pressure-dependent 
flow pattern. On the contrary, in cases of extrinsic compression 
usually caused by aberrant vessels, urine flow is impeded only 
after a definite amount of urine is collected in the renal pelvis. 
This is an example of volume-dependent flow, and the pressure 
damage is only evident intermittently; thus, the degree of 
damage generally is less than that of intrinsic obstruction.
　Significant urinary obstruction invariably results in tubular 
dilation, glomerulosclerosis, inflammation, and fibrosis,23 not 
only in the affected kidney, but also in the contralateral 
kidney.24 Although not absolute, a good correlation exists 
between the severity of these histologic changes and the 
function remaining in the affected kidneys. Sclerotic glomeruli 
and fibrosis are reliably localized to areas of the kidney that 
demonstrate the most inflammatory infiltrate. The infiltrate 
consists mostly of mononuclear cells in both the cortex and 
medulla.25 The cells predominantly are macrophages, though a 
small number of T cells are present.26
　The activation of the renin-angiotensin system is a major 
factor in partial obstruction.27 Administration of the angioten-
sin-converting enzyme (ACE) inhibitor enalapril not only 
maintained RBF in partially obstructed kidneys at 3 weeks 
post-obstruction but also prevented the histologic changes of 
glomerulosclerosis.28 The effects of obstruction are not all 
ischemic. Obstruction can mimic renal artery stenosis, and, 
because of its intense vasoconstrictor action, the resulting 
increase in angiotensin II (AII) leads to decreases in GFR. It 
is becoming increasingly clear, however, that AII profoundly 
affects the expression of growth factors in the developing 
kidney that ultimately are responsible for the changes in the 
histology. Up regulation of TGF is apparent in these infiltrating 
cells, and the degree of up regulation correlates directly with 
fibrosis and collagen deposition in obstructed kidneys.29
WORKUP
1. Laboratory studies
　Novel approaches may discern the clinically significant UPJ 
obstruction.
  1) β2-microglobulin: Disruption of proximal tubular inte-
grity leads to increased urinary concentrations of β2-micro-
globulin (B2M), which normally is resorbed from the tubular 
lumen via phagocytosis and lysosomal digestion.30
　Functionally significant obstruction and recovery from ob-
struction may be determined by following the urinary concen-
tration of B2M.31 However, many different insults other than 
UPJ obstruction can lead to increased levels of B2M in the 
urine.
　2) N-acetyl-β-D-glucosaminidase (NAG): NAG is a tubu-
lar lysosomal enzyme present in the urine of children who have 
various renal diseases.
　In rats with experimental partial ureteral obstruction, the 
urinary concentration of NAG increases in the first 2 weeks of 
obstruction and decreases with the relief of obstruction.32 In a 
clinical study, urinary NAG levels in kidneys at the time of 
pyeloplasty were 7 fold higher than in bladder compared to 
normal controls. In addition, enzyme levels in the bladder of 
patients 6 weeks after surgery suggested normalization of NAG 
excretion.32
　3) Other biochemical markers: The assessment of urine for 
growth factors (eg, epidermal growth factor [EGF], platelet- 
derived growth factor [PDGF], TGF-β1), cytokines, and vaso-
active substances may be an important adjunct in evaluating 
obstructive uropathy in the future.
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Table 1. Diuresis renography pitfalls
 1. Severity of obstruction
 2. Variable impairments of renal function
 3. Volume capacity of the pelvis, ureter or bladder
 4. Hydration state
 5. Bladder fullness
 6. Patient positioning
 7. Radiopharmaceutical
 8. Region of interest
 9. Patient movement
10. Dose and choice of diuretic
11. Time at which diuretic is given
12 Method of data interpretation
Presented by M. Majd at the American Academy of Pediatrics 
Meeting, Chicago, IL, 1989
IMAGING STUDIES
1. Prenatal
　During any session of prenatal ultrasonographic diagnosis, 
thoroughly investigate the following from the initial study 
usually performed between 16 and 20 weeks: amniotic fluid 
volume to rule out oligohydramnios, bladder volume, kidney 
size, anteroposterior diameter of the renal pelvis, and any 
associated abnormalities. Following fetal hydronephrosis also is 
important to monitor possible progression. A meta-analysis of 
7 studies on isolated antenatal hydronephrosis showed that 98% 
of patients with Society of Fetal Urology (SFU) grades33 1-2 
hydronephrosis (anterior-posterior pelvic diameter [APPD] 
＜12 mm) resolved, stabilized, or improved during follow-up.
2. Postnatal
　1) Ultrasound: After the prenatal presumptive diagnosis UPJ 
obstruction or other conditions causing hydronephrosis is made, 
the neonate should undergo ultrasonographic evaluation on the 
second or third day of life. Before this date, results may be 
false negative because of neonatal dehydration and physiologic 
oliguria; however, in cases of bilateral hydronephrosis, more 
rapid evaluation is warranted. Postnatal examination evaluation 
consists of urinary tract study whether the calyceal pelvic 
dilation with or without renal cortical thinning is present. 
Approximately 20% of antenatal hydronephrosis are not found 
on postnatal ultrasonogram.34 Doppler sonography is especially 
reliable in the preoperative diagnosis of aberrant-accessory 
blood vessels associated with UPJ obstruction.35,36 At the same 
time, ultrasonographic evaluation on the contralateral kidney, 
bladder, and ureter is performed.
　2) Radionuclide renography: The renal scan and scinti-
graphy (ie, diuretic renogram) is the most widely used tech-
nique in the presence of hydronephrosis to assess function and 
obstruction.37 The rate at which tracer leaves the renal pelvis 
following diuretic injection, reflected in the slope of the 
drainage curve and often reported as T1/2 (the time required 
for 50% of the isotope to exit), is generally viewed as a 
reflection of the patency of the UPJ. Rapid drainage indicates 
no obstruction, while impaired drainage or slow or no washout 
(T1/2 ＞20 min) indicates obstruction.
　The current radiopharmaceutical agent most widely used is 
technetium 99m diethylenetriamine pentaacetic acid (99mTc- 
DTPA). It is excreted by glomerular filtration and is not 
secreted or reabsorbed by the renal tubules.38 Another agent is 
99mTc-mercaptoacetyltriglyine (MAG3), which offers better 
anatomical resolution and can be used in case of decreased 
renal function. Variables include the use of intravenous hydra-
tion, the dosage and timing of administration of diuretic, the 
requirement for bladder catheterization, the degree of pelvic 
dilatation, the severity of outflow obstruction, and the method 
of calculating the clearance after the administration of 
diuretic.39,40 In order to overcome such variables, Conway and 
Maizels suggested the use of a “well tempered” diuretic 
renogram in neonates with hydronephrosis.41
　The most useful measure in diuretic renography is the 
estimate of differential renal function. This is considered 
significant when it is less than 40%. This percentage usually 
is well correlated with the half-life (T1/2) washout curve. As 
stated above, many factors must be considered when evaluating 
the renal scan, especially in neonates (Table 1). For this reason, 
the T1/2 of the diuretic renogram cannot be a single indicator 
to determine surgery, especially in the neonate.
3. Supranormal renal function
　Although it is postulated that significant obstruction results 
in decreased ipsilateral renal function, we often see maintained 
or even increased differential renal function on a renal scan of 
a large hydronephrotic kidneys. This paradoxically increased 
renal function, the so-called supranormal renal function, is 
usually defined as a differential renal function greater than 
55%, given that the contralateral kidney and bladder function 
are normal.42 It has been hypothesized to be caused by an 
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increase in single nephron filtration or nephron volume.42 
However, in a study of histopathological changes of hydro-
nephrotic kidneys with supranormal DRF assessed with intra-
operative kidney biopsy at the time of pyeloplasty, the 
glomerular area was not significantly larger than controls, but 
the probability for a larger renal glomeruli increased with 
decreasing DRF.43 Instead of increased nephron volume, the 
supranormal DRF can be accounted for by an increase in renal 
blood flow that results from tubuloglomerular feedback, 
prostaglandins, and the renin-angiotensin system as a protective 
mechanism from high intrapelvic pressure.
TREATMENT
1. Medical therapy
　The timing of surgical correction of hydronephrosis sugges-
tive of UPJ obstruction in newborns is highly controversial. 
Those who support delayed management contend that for most 
newborns with relatively preserved differential renal function 
(＞35% of differential renal function), hydronephrosis is a 
relatively benign disease without proof of progression.44,45 
Renal function does not deteriorate; thus, immediate surgery is 
not necessary. In a study by Koff and associates,46 approxi-
mately 81 out of 104 patients were followed for 5 years; 7 (7%) 
of those patients ultimately required pyeloplasty, and, even in 
these cases, pyeloplasty successfully restored the differential 
renal function to pre-deterioration levels. Onen et al. suggested 
that nonoperative management with close follow up during the 
first 2 years appears to be a safe approach even in neonates 
with severe bilateral UPJ obstruction.47
　Researchers also observed that in 15 out of 16 patients with 
severe hydronephrosis (grade 4 hydronephrosis according to the 
SFU Guidelines) associated with a differential renal function of 
less than 40%, spontaneous improvement occurred in the initial 
obstructive patterns on renal scans, and, for 6 of the patients, 
it became non-obstructed. Similar results were observed with 
ultrasonography that hydronephrosis disappeared in 6 kidneys 
and improved in another 6 kidneys.
　Thus, the difficulty in determining the indication of surgical 
management is 2-fold. First, ultrasonography and diuretic reno-
graphy to assess hydronephrosis are inaccurate and sometimes 
misleading. Second, some significant cases of hydronephrosis 
that are discovered by these modalities may not be obstructive 
at all. Therefore, Koff redefined obstruction as “any restriction 
to urinary outflow, which if untreated will injure the kidney” 
to provide a clinically useful guideline; Koff recommended that 
most unilateral hydronephrosis actually is non-obstructed and, 
thus, benign, which can be observed safely nonoperatively.48
2. Surgical therapy
　Physiologically, the newborn kidney is quite different than 
the adult kidney, particularly in the response to stimulation by 
the renin-angiotensin system. Renal function could be preserved 
by relieving the obstruction, achieving maximal benefit in the 
youngest of kidneys.49,50
　Unilateral pyeloplasty not only improves hydronephrosis but 
also significantly increases creatinine clearance (as calculated 
by the Schwartz formula) and somatic growth.51 The implica-
tion is that unilateral obstruction has negative effects on renal 
function and on somatic growth. Spontaneous resolution of 
hydronephrosis is not as benign as proposed by Koff and 
Campbell, that is 15-33% of patients with asymptomatic neo-
natal hydronephrosis show progressive ipsilateral renal deter-
ioration, and about one half of them never regain the lost 
function by pyeloplasty.52
　There are 2 well-designed longitudinal studies that provide 
valuable information against initial observation and delayed 
management. According to the study by Ransley53 and asso-
ciates, of 100 infants with DRF of hydronephrotic kidney 
higher than 40% who were followed non-operatively, 23 even-
tually underwent pyeloplasty during 6 years of follow-up care. 
Among these patients, 5 (36%) completely recovered renal 
function, 4 (29%) partially recovered, 3 (21%) had no change, 
and 1 (7%) further deteriorated after pyeloplasty. Thus, 8 of 
100 initially well-functioning kidneys sustained permanent 
deterioration with this approach. Similar results were observed 
by Cartwright and Duckett,54 which included the results with 
39 infants with a cut-off value of 35% of differential renal 
function. Six patients (15%) underwent pyeloplasty because of 
decreasing renal function, UTI, or pain.
　A differential renal function below 40% in unilateral hydro-
nephrosis with a normal contralateral kidney, recurrent urinary 
tract infections in spite of antibiotic prophylaxis and rapid 
aggravation of hydronephrosis on serial renal ultrasound or 
severe bilateral hydronephrosis seem to be universally recog-
nized as indications for surgical intervention.55
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Fig. 1. The type of ureteral narrowing. (A) Narrowing of the UPJ only. (B) Multiple ureteral narrowing. (C, D) Hypoplastic ureters (Adopted 
from Kim et al. Korean J Urol 2003;44:550-5). UPJ: ureteropelvic junction.
CONVENTIONAL OPEN SURGICAL REPAIRS
　The technique of complete ureteral transection followed by 
reanastomosis to the renal pelvis was first described in the 
management of a retrocaval ureter, but it was easily adapted 
for reconstructing the UPJ obstruction. Many different appro-
aches have been tried, such as lumbotomy, flank, or anterior 
extraperitoneal incision, but the essence of repair consists of 
excision of the narrowed segment, spatulation, and anastomosis 
to the most dependent portion of the renal pelvis. Foley 
YV-plasty, a non-dismembered type of repair, is useful in the 
repair of a kidney with high ureteral insertion and most cases 
of horseshoe kidneys; however, the Anderson-Hynes pyelo-
plasty, the most commonly used type of repair, has a high 
success rate with few complications in most cases.56,57
ENDOUROLOGICAL TECHNIQUES
　Endourologic methods applied on UPJ obstruction include 
balloon dilatations, percutaneous antegrade endopyelotomy, and 
retrograde ureteroscopic endopyelotomy. In 1983, Wickham 
and Kellet established access to a hydronephrotic kidney and 
performed the first percutaneous pyelolysis.58 Soon, a large 
series of endopyelotomies in adults was reported with fairly 
good short- and long-term success rates of 70-85%. If an initial 
attempt of endopyelotomy fails, subsequent open pyeloplasty is 
still a viable option with a high success rate.
LAPAROSCOPIC TECHNIQUES
　Laparoscopic dismembered pyeloplasty, first introduced in 
1993 by Schuessler,59 yields results that are comparable with 
those of open pyeloplasty, with success rates reported to be as 
high as 96-98% while still maintaining the benefits of endo-
scopic approaches, including less postoperative pain, short 
hospitalization, and reduced postoperative recovery time. 
Nowadays, despite the disadvantage of a limited working space, 
retroperitoneal laparoscopic pyeloplasties are becoming popular 
since unnecessary handling of the bowel can be avoided. 
However, the technical skills required for intracorporeal sutur-
ing and the lengthy operation time due to the degree of 
difficulty make it a costly procedure. The introduction of 
robot-assisted techniques have greatly facilitated the suturing 
and has become an attractive treatment option but the high cost 
still remains an obstacle toward the popularization of this 
technique.
POSTOPERATIVE OUTCOME AND PROGNOSIS
　The overall success rate with the dismembered repair is quite 
satisfactory; most series report a success rate of higher than 
90-95%. Long-term obstruction at the anastomosis can occur; 
but reoperation rate for this is low, occurring in 2-5% of cases.
　Bleeding and infection are uncommon following pyeloplasty. 
Of those with hydronephrosis and preserved renal function at 
neonatal evaluation, 23% presented for delayed surgery in one 
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series. On the other hand, some propose delaying surgical 
correction because newborn hydronephrosis is a relatively 
benign condition and a definite proportion of patients have 
spontaneous improvement.
　The common early complications are prolonged urinary 
extravasation and delayed opening of the anastomosis. Urinary 
extravasation usually stops spontaneously, generally within 2 
weeks. Delay in opening of the anastomosis is observed most 
often with the use of a nephrostomy tube without a stent across 
the anastomosis. Within 3 months of surgery, 80% of ob-
structed anastomosis eventually open. According to our review, 
significant improvements in hydronephrosis could be observed 
until 6 months postoperatively, but no significant changed 
occurred beyond 6 months.60
　Numerous prognostic factors have been investigated to pre-
dict the postoperative outcome. In a review of 30 patients who 
underwent pyeloplasty for unilateral UPJ onstruction by Park 
et al, they found no significant difference in the age, sex, 
history of UTI, anteroposterior diameter of renal pelvis, paren-
chymal thickness or laterality between the group which showed 
improvement and aggravation following pyeloplasty.61
　The value of visualizing the ureter and the clinical signifi-
cance of the ureter morphology has been suggested by several 
studies. Cockrell reported that 36% of his patients had “more 
than a simple narrowing” in the UPJ, and suggested visua-
lization of ureters could contribute to successful surgery.62 In 
our study of intraoperative retrograde pyelograms, patients with 
hypoplastic ureters tended to show a slower improvement rate 
compared to other types of ureteral narrowing (Fig. 1).63
　Patients with lower percentages of elastin in the renal pelvis, 
UPJ proper, or ureter tended to show better resolution of 
hydronephrosis 6 months after pyeloplasty. Increased elastin of 
the renal pelvis and ureter might result in inelasticity and low 
compliance, which delays hydronephrosis improvement after 
pyeloplasty.64
　The meaning of supranormal function and its implication in 
postoperative renal function also warrants further investigation. 
Although some authors have suggested that the supranormal 
function reprsents a true renal function of the affected kidney 
and remains supranormal even after pyeloplasty in most cases,65 
it is debatable whether supranormal function can be considered 
as a favorable prognostic factor and longer follow up is needed. 
CONCLUSION
　In spite of the vast number of reports and research per-
formed, ureteropelvic junction obstruction has not been 
completely uncovered. Finding an accurate, yet easily appli-
cable method of evaluating the true renal function might bring 
along major changes both in the diagnosis and treatment of the 
disease.
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